Skip to main content
OpenTrials

Clinical trial condition

Immunoblastic Lymphadenopathy

Explore clinical trials studying Immunoblastic Lymphadenopathy. Study availability and eligibility vary by location and protocol.

192 public trials 11 recruiting studies

Immunoblastic Lymphadenopathy trial results

Conditions
Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoblastic Lymphadenopathy, +14 more
Locations
  • U.Z. Gasthuisberg Leuven, Belgium
  • Algemeen Ziekenhuis Sint-Augustinus Wilrijk, Belgium
  • University Hospital Rebro Zagreb, Croatia
  • National Cancer Institute - Cairo Cairo, Egypt
Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoblastic Lymphadenopathy, +10 more
Locations
  • Ziekenhuis Network Antwerpen Middelheim Antwerp, Belgium
  • Centre Hospitalier Universitaire Brugmann Brussels, Belgium
  • U.Z. Gasthuisberg Leuven, Belgium
  • National Cancer Institute of Egypt Cairo, Egypt
View all 17 locations
Conditions
Adnexal Diseases, Amyloidosis, Ataxia, +137 more
Locations
  • CHU Liege - Domaine Universitaire du Sart Tilman Liège, Belgium
  • Centre Hospitalier Universitaire Henri Mondor Créteil, France
  • Hopital Edouard Herriot - Lyon Lyon, France
  • Hopital Saint-Louis Paris, France
View all 13 locations